Browse Data and Analysis

This is a regional report on West Africa that primarily covers Senegal, Burkina Faso, and Mali, but also provides brief overviews in certain sections for Niger, The Gambia, Guinea, Guinea-Bissau, and Mauritania.

With international funding to develop and implement biosafety regulatory systems drying up in 2019, Caribbean biosafety regulatory efforts remain in idle mode. The region is seeking further funding from the United Nations Environmental Program/Global...

Biosafety regulatory efforts in the Caribbean remain stalled, and it is yet to be seen whether countries can regain the will and secure the international financing required to fully implement their National Biosafety Frameworks in a harmonized manner.

In September 2021, the Government of Niger signed the ministerial decree that defines the composition, organization, and function of the National Technical and Scientific Committee on Biosafety (CTSNB).

The Government of Senegal is reviewing and revising its new biosafety law which may include language for an expedited approval process for certain genetically engineered (GE) products.

Many Caribbean Community (CARICOM) Member States have undertaken efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Many Caribbean Community (CARICOM) Member States have engaged in efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead....

Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead as 12 Caribbean Community (CARICOM) countries move forward with a United Nations...

Caribbean nations are very heterogeneous in terms of history, culture, and GDP.

Biotech regulation has been virtually non-existent in the Caribbean.

Since January 2014, the Burkinabe National Biosafety Agency (NBA) has been converting the status of the organization to a technical and scientific public institution (EPSET) for greater autonomy.